U.S. employers getting creative to offset the high cost of specialty drugs

According to a recent survey of 610 U.S. employers by advisory firm Willis Towers Watson found employers are trying to offset the high cost of specialty drugs by influencing where those drugs are delivered and exploring how to leverage biosimilars.  This year 21 percent employers shared the creative ways which include the site of care for delivering specialty drugs which could dramatically affect prices as it is cheaper to deliver drugs in a patient’s home or physician’s office as opposed to a hospital. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.